Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Scientists find few links between cancer and microbiome
About a dozen studies in the past five years have made claims linking nearly every…
Patient-reported outcomes provide independent prognostic information in cancer
A new systematic review and meta-analysis published in JAMA Oncology suggests that patient-reported outcomes (PROs)…
Immunotherapy duo shows promise in Australian rare ovarian and endometrial clear cell cancers study
A phase 2 Australian-New Zealand study has reported encouraging results for the combination of nivolumab…
The OJC 55: The Gut Microbiota, Electronic Health Records and COVID Risks
The Oncology Journal Club Episode 55: The Gut Microbiota, Electronic Health Records and COVID Risks This week Eva talks us…
Wear and tear from lifelong stress can increase cancer mortality
The wear and tear on the body from chronic and lifelong stress can also lead to an increased risk of…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.